Teladoc Health Reports Mixed Results for Full Year and Fourth Quarter 2024
In a press release dated February 26, 2025, Teladoc Health, Inc. (NYSE: TDOC), the leader in whole-person virtual care, announced its financial results for the full year and fourth quarter of 2024. Despite a solid finish to the year and the advancement of key initiatives, the company faced challenges that led to declines in revenue and significant net losses.
1. Financial Performance Overview
Key Financial Highlights
- Full Year Revenue: $2,569.6 million, down 1% year-over-year.
- Fourth Quarter Revenue: $640.5 million, down 3% year-over-year.
- Full Year Net Loss: $1,001.2 million, or $5.87 per share.
- Fourth Quarter Net Loss: $48.4 million, or $0.28 per share.
- Adjusted EBITDA: Full Year 2024 at $310.7 million, down 5% year-over-year, and Fourth Quarter 2024 at $74.8 million, down a substantial 35% year-over-year.
CEO Chuck Divita remarked, “We had a solid finish to the year, both in terms of performance and advancing initiatives important to our future.” The results highlighted the ongoing challenges in the operating environment, particularly in the BetterHelp segment.
Segment Performance
The report revealed mixed results across the company's segments. The Integrated Care segment showed resilience with a 2% revenue increase in the fourth quarter, totaling $390.7 million. In contrast, the BetterHelp segment struggled, experiencing a 10% decline in revenue, dropping to $249.8 million.
Revenue Breakdown
- Access Fees Revenue: Decreased 5% to $543.1 million in Q4 2024.
- International Revenue: Grew by 10% to $105.1 million in Q4 2024, contrasting with a 5% decrease in U.S. revenue.
2. Financial Challenges
Despite the highlights, the financial results were overshadowed by a significant non-cash goodwill impairment charge of $790 million attributed to the BetterHelp segment. This charge heavily influenced the overall net loss for the year.
Cash Flow and Capital Expenditures
Teladoc reported an operating cash flow of $293.7 million for the full year, down from $350 million in 2023. Free cash flow also saw a dip, totaling $169.6 million, compared to $193.7 million in the prior year. The company maintained a robust cash position of $1,298.3 million as of December 31, 2024.
3. 2025 Financial Outlook
Looking ahead, Teladoc Health provided guidance for 2025, anticipating a revenue range of $2,468 million to $2,576 million. The company expects to generate adjusted EBITDA between $278 million and $319 million, with a projected net loss per share ranging from ($1.10) to ($0.50).
Segment-Specific Expectations
- Integrated Care: Projected revenue growth of 0% to 3% year-over-year.
- BetterHelp: Expected decline in revenue growth of 9.75% to 3.75% year-over-year.
Divita emphasized the importance of execution as the company aims to unlock growth opportunities and focus on cost management.
4. Conclusion
Teladoc Health's financial results for 2024 illustrate a company in transition, grappling with challenges in its BetterHelp segment while managing growth in Integrated Care. With a focus on stabilizing results and preparing for future growth, Teladoc is strategically positioned to navigate the complexities of the virtual healthcare landscape. Investors will be keenly watching how the company implements its plans and responds to market conditions in 2025.
The earnings conference call is scheduled for later today at 4:30 p.m. ET, providing an opportunity for stakeholders to gain further insights into the company's strategy moving forward.
